July 4, 2011

Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support)


Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177

Warning: Invalid argument supplied for foreach() in /nfs/c04/h03/mnt/65750/domains/transplantnow.com/html/wp-content/themes/nephrology/scripts/pubmed.php on line 177
.   .   

Outcomes for patients supported on mechanical circulatory support continue to improve.The results of this post-approval study support the original findings from the pivotal clinical trial regarding the efficacyand risk profile of the HM II LVAD in a post-marketapproval “real world” BTT (Bridge to Transplant) population.Trends in patient selection and outcome are described.  Favorable improvements in 30-day mortality and 1 year survival are presented.

 

Cardiac Transplantation

Tags: , , , , ,